Pseudoprogeria syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2985OMIM:200130Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pseudoprogeria syndrome, also known as Hallermann-Streiff syndrome (HSS) or Hallermann-Streiff-François syndrome, is a rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dermatological, and skeletal abnormalities that give affected individuals a prematurely aged (progeroid) appearance. The condition is sometimes also referred to as oculomandibulodyscephaly or dyscephalia mandibulo-oculofacialis. Key clinical features include a characteristic bird-like facial appearance (brachycephaly with frontal bossing, a thin pointed nose, and micrognathia or small jaw), bilateral congenital cataracts, microphthalmia (small eyes), dental anomalies (such as natal teeth, supernumerary teeth, or hypodontia), proportionate short stature, and hypotrichosis (sparse hair), particularly of the scalp, eyebrows, and eyelashes. Skin atrophy, especially over the nose and scalp, contributes to the aged appearance. Additional features may include upper airway obstruction related to the mandibular hypoplasia, which can cause significant respiratory difficulties, particularly in infancy. Intellectual development is typically normal, though some patients may have mild intellectual disability. There is no specific cure or targeted therapy for pseudoprogeria syndrome. Management is multidisciplinary and symptomatic, focusing on ophthalmologic care (including early cataract surgery), dental management, monitoring and treatment of airway obstruction (which may require tracheostomy in severe cases), and orthopedic surveillance. Nutritional support may be needed in infancy due to feeding difficulties associated with the small jaw. Genetic counseling is recommended for affected families, though the exact genetic basis remains incompletely understood in most cases.

Also known as:

Clinical phenotype terms— hover any for plain English:

Absent eyelashesHP:0000561Bird-like faciesHP:0000320Progressive spastic quadriplegiaHP:0002478Cranium bifidum occultumHP:0004423Spinal arachnoid cystHP:0009745Narrow nasal tipHP:0011832
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pseudoprogeria syndrome.

View clinical trials →

No actively recruiting trials found for Pseudoprogeria syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pseudoprogeria syndrome community →

No specialists are currently listed for Pseudoprogeria syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pseudoprogeria syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pseudoprogeria syndromeForum →

No community posts yet. Be the first to share your experience with Pseudoprogeria syndrome.

Start the conversation →

Latest news about Pseudoprogeria syndrome

No recent news articles for Pseudoprogeria syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pseudoprogeria syndrome

What is Pseudoprogeria syndrome?

Pseudoprogeria syndrome, also known as Hallermann-Streiff syndrome (HSS) or Hallermann-Streiff-François syndrome, is a rare congenital disorder characterized by a distinctive combination of craniofacial, ocular, dermatological, and skeletal abnormalities that give affected individuals a prematurely aged (progeroid) appearance. The condition is sometimes also referred to as oculomandibulodyscephaly or dyscephalia mandibulo-oculofacialis. Key clinical features include a characteristic bird-like facial appearance (brachycephaly with frontal bossing, a thin pointed nose, and micrognathia or small

How is Pseudoprogeria syndrome inherited?

Pseudoprogeria syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pseudoprogeria syndrome typically begin?

Typical onset of Pseudoprogeria syndrome is neonatal. Age of onset can vary across affected individuals.